U.S. trial tests ivonescimab for advanced biliary tract cancer
A National Cancer Institute-funded phase 2/3 trial will test ivonescimab plus chemotherapy against standard chemoimmunotherapy in U.S. patients with advanced ...
A National Cancer Institute-funded phase 2/3 trial will test ivonescimab plus chemotherapy against standard chemoimmunotherapy in U.S. patients with advanced ...
A 2026 case report describes a 42-year-old man whose bleeding splenic lesions were diagnosed as primary splenic angiosarcoma after splenectomy, ...
In a two-center observational cohort of 120 patients with advanced NSCLC and COPD, higher serum IL-6 measured after six treatment ...
A retrospective, cross-sectional study found cryptococcal antigenemia in 11.1% of 63 hospitalized patients with advanced HIV in Fortaleza and an ...
A retrospective single-center study found that at least 20% early tumor shrinkage was associated with longer progression-free survival after first-line ...
A review evaluates circulating tumor DNA testing for detecting ESR1-mutant clones and organizing treatment sequencing in hormone receptor-positive, HER2-negative advanced ...
A retrospective single-center cohort of 128 patients associated frontline bevacizumab with longer overall survival in advanced ovarian cancer, while clear ...
A small Indian pilot study finds that the microRNA hsa-miR-26a-5p is consistently and strongly upregulated in advanced oral squamous cell ...
A prospective study finds that dynamic contrast-enhanced MRI detects significant vascular changes in brain metastases within four to eight weeks ...
A multicountry survey of patients and oncologists in France, Italy, and Spain reveals persistent mismatches in knowledge, priorities, and communication ...
A sixteen-year retrospective cohort study in Senegal found that 19.1 percent of children with congenital anomalies of the kidney and ...
A 1,500-patient next-generation sequencing study from Gazi University reveals EGFR and KRAS as dominant drivers in advanced NSCLC, with distinct ...
A Bayesian network meta-analysis of 19 studies finds that EGFR inhibitors combined with PD-L1 blockade show a strong response signal ...
A retrospective study finds that elevated alpha-fetoprotein in pancreatic cancer is linked to advanced disease stage but does not independently ...
A large SEER database analysis presented at the American College of Surgeons Clinical Congress 2026 shows that patients aged 45 ...
A controversial clinical trial has once again thrust homeopathy into the center of a scientific firestorm. In a prospective, randomized, ...
A comprehensive review in Discover Chemistry evaluates advanced formulation strategies, from solid dispersions and novel salt forms to polymeric micelles ...
UChicago Medicine has launched a first-of-its-kind investigator-initiated clinical trial of a fully on-site manufactured T-cell receptor therapy engineered to target ...
A new correspondence in Supportive Care in Cancer argues that sleep disturbance in palliative care patients deserves sharper clinical attention, ...
A sweeping new review reveals how multimodal neuroimaging, from strategic infarct mapping to AI-driven small vessel disease scoring, is transforming ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.